Nyxoah Reports First Quarter 2026 Financial and Operating Results
May 13, 2026 - 03:39
Nyxoah SA, a medical technology company developing treatments for Obstructive Sleep Apnea, reported its financial and operating results for the first quarter of 2026 on May 12. The company pointed to a strong launch of its Genio system in the United States as a key driver of performance.
According to the report, U.S. revenue for the Genio device grew 25% on a sequential quarterly basis. This marks continued momentum for the system, which is designed to treat obstructive sleep apnea through hypoglossal nerve stimulation.
The company also noted increased clarity regarding reimbursement for both the Genio system and the broader hypoglossal nerve stimulation (HGNS) category in the U.S. market. This development is expected to support further adoption by patients and healthcare providers.
Nyxoah is headquartered in Mont-Saint-Guibert, Belgium, and is listed on both Euronext Brussels and the Nasdaq under the ticker NYXH. The company remains focused on expanding its commercial footprint and advancing its technology platform.
MORE NEWS
June 27, 2026 - 01:59
Where today's AI trade opportunities areKenny Glick, owner of HIT-THE-BID.COM, recently joined Jared Blikre on Market Domination to break down the current landscape for AI-related trades. Glick emphasized that while the AI sector remains...
June 26, 2026 - 02:18
How digital payments are reshaping a fast-growing digital banking marketAs digital payments become a normal part of daily life in Uzbekistan, the country`s banks are racing to offer more than just basic accounts. Lending, insurance, and investment products are now...
June 25, 2026 - 22:50
Financial Advisors Looking for New Clients Shouldn’t Overlook First-Time ParentsFinancial advisors searching for new clients might be missing a major opportunity right under their noses: first-time parents. While many advisors focus on retirees or high-net-worth individuals,...
June 25, 2026 - 05:01
Investors Are Using AI for Financial Decisions. They Still Want a Human Advisor.A recent survey commissioned by HSBC reveals a clear split in how U.S. investors approach their financial decisions. While artificial intelligence tools are gaining traction for research and quick...